Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19): A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial.
AuteursTerzić V, Miantezila Basilua J, Billard N, de Gastines L, Belhadi D, Fougerou-Leurent C, Peiffer-Smadja N, Mercier N, Delmas C, Ferrane A, Dechanet A, Poissy J, Espérou H, Ader F, Hites M, Andrejak C, Greil R, Paiva JA, Staub T, Tacconelli E, Burdet C, Costagliola D, Mentré F, Yazdanpanah Y, Diallo A
Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.
AuteursJacobs L, Wauters N, Lablad Y, Morelle J, Taghavi M
Impact of scatter correction on personalized dosimetry in selective internal radiotherapy using <sup>166</sup>Ho-PLLA: a single-center study including Monte-Carlo simulation, phantom and patient imaging.
AuteursCollette B, Mannie-Corbisier M, Bucalau AM, Pauly N, Verset G, Moreno-Reyes R, Flamen P, Trotta N
Impact of scatter correction on personalized dosimetry in selective internal radiotherapy using <sup>166</sup>Ho-PLLA: a single-center study including Monte-Carlo simulation, phantom and patient imaging.
AuteursCollette B, Mannie-Corbisier M, Bucalau AM, Pauly N, Verset G, Moreno-Reyes R, Flamen P, Trotta N
